Abstract
The decreasing cost of high-throughput technologies allows to consider their use in healthcare and medicine. To prepare for this upcoming revolution, the community is assembling large disease-dedicated datasets such as TCGA or METABRIC. These datasets will serve as references to compare new patient samples to in order to assign them to a predefined category (i.e. ‘patients associated with poor prognosis’). Some problems affecting the downstream analysis remain to be solved, the bottleneck is no longer data generation itself but the integration of the existing datasets with the present knowledge. Constraint-based modelling, that only requires the setting of a few parameters, became popular for the integration of high-throughput data in a metabolic context. Notably, context-specific building algorithms that extract a subnetwork from a reference network are largely used to study metabolic changes in various diseases. Reference networks are composed of canonical pathways while extracted subnetworks include only active pathways in the context of interest based on high-throughput data. Even though these algorithms can be part of automated pipelines, to be applied by clinicians, the model-building pipelines must be coupled to a standardized semi-automated analysis workflow based on machine learning approaches to avoid bias and reduce the cost of diagnostics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agren R, Bordel S, Mardinoglu A, Pornputtapong N, Nookaew I, Nielsen J (2012) Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Comput Biol 8(5):e1002518
Angione C, Lió P (2015) Predictive analytics of environmental adaptability in multi-omic network models. Sci Rep 5:15147
Asgari Y, Zabihinpour Z, Salehzadeh-Yazdi A, Schreiber F, Masoudi-Nejad A (2015) Alterations in cancer cell metabolism: the Warburg effect and metabolic adaptation. Genomics 105(5):275–281
Askari BS, Krajinovic M (2010) Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes. Curr Genomics 11(8):578–583
Aurich MK, Fleming RM, Thiele I (2017) A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines. PLoS Comput Biol 13(8):e1005698
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2(1)
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603–607
Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, Ebright RY, Stewart ML, Ito D, Wang S et al (2013) An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154(5):1151–1161
Becker SA, Palsson BO (2008) Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol 4(5):e1000082
Boehm JS, Golub TR (2015) An ecosystem of cancer cell line factories to support a cancer dependency map. Nat Rev Genet 16(7):373
Bordbar A, Monk JM, King ZA, Palsson BO (2014) Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet 15(2):107
Clarke C, Doolan P, Barron N, Meleady P, O’Sullivan F, Gammell P, Melville M, Leonard M, Clynes M (2011) Large scale microarray profiling and coexpression network analysis of CHO cells identifies transcriptional modules associated with growth and productivity. J Biotechnol 155(3):350–359
Conde M, do Rosario P, Sauter T, Pfau T (2016) Constraint based modeling going multicellular. Front Mol Biosci 3:3
Consortium GP et al (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061–1073
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346–352
Diener C, Resendis-Antonio O (2016) Personalized prediction of proliferation rates and metabolic liabilities in cancer biopsies. Front Physiol 7
Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BØ (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci 104(6):1777–1782
Estévez SR, Nikoloski Z (2015) Context-specific metabolic model extraction based on regularized least squares optimization. PloS One 10(7):e0131875
Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7(1):501
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A et al (2010) Cosmic: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 39(suppl\(\_\)1):D945–D950
Franke RM, Scherkenbach LA, Sparreboom A (2009) Pharmacogenetics of the organic anion transporting polypeptide 1A2
Frejno M, Chiozzi RZ, Wilhelm M, Koch H, Zheng R, Klaeger S, Ruprecht B, Meng C, Kramer K, Jarzab A et al (2017) Pharmacoproteomic characterisation of human colon and rectal cancer. Mol Syst Biol 13(11):951
Gibbs RA, Belmont JW, Hardenbol P, Willis TD, Yu F, Yang H, Ch’ang LY, Huang W, Liu B, Shen Y et al (2003) The international HapMap project. Nature 426(6968):789–796
Goh WWB, Wang W, Wong L (2017) Why batch effects matter in omics data, and how to avoid them. Trends Biotechnol
Guinney J, Dienstmann R, Wang X, De Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21(11):1350
Halldorsson S, Rohatgi N, Magnusdottir M, Choudhary KS, Gudjonsson T, Knutsen E, Barkovskaya A, Hilmarsdottir B, Perander M, Mælandsmo GM et al (2017) Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition. Cancer Lett 396:117–129
Hart T, Brown KR, Sircoulomb F, Rottapel R, Moffat J (2014) Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol Syst Biol 10(7):733
Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S et al (2015) High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163(6):1515–1526
Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH (1997) Integrating genetic approaches into the discovery of anticancer drugs. Science 278(5340):1064–1068
Hefzi H, Ang KS, Hanscho M, Bordbar A, Ruckerbauer D, Lakshmanan M, Orellana CA, Baycin-Hizal D, Huang Y, Ley D et al (2016) A consensus genome-scale reconstruction of Chinese hamster ovary cell metabolism. Cell Syst 3(5):434–443
Heinken A, Sahoo S, Fleming RM, Thiele I (2013) Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes 4(1):28–40
Hillje AL, Beckmann E, Pavlou MA, Jaeger C, Pacheco MP, Sauter T, Schwamborn JC, Lewejohann L (2015) The neural stem cell fate determinant TRIM32 regulates complex behavioral traits. Front Cell Neurosci 9:75
Ho YC, Pepyne DL (2002) Simple explanation of the no-free-lunch theorem and its implications. J Optim Theory Appl 115(3):549–570
Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gonçalves E, Barthorpe S, Lightfoot H et al (2016) A landscape of pharmacogenomic interactions in cancer. Cell 166(3):740–754
James G, Witten D, Hastie T, Tibshirani R (2013) An introduction to statistical learning, vol 112. Springer, Berlin
Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2009) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38(suppl\(\_\)1):D355–D360
Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H, Degenhardt J, Mayba O, Gnad F, Liu J et al (2015) A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol 33(3):306–312
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V et al (2010) DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 39(suppl\(\_\)1):D1035–D1041
Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera MDC, Yusa K (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32(3):267
Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3(8):711
Kotsiantis SB, Zaharakis I, Pintelas P (2007) Supervised machine learning: a review of classification techniques. Emerg Artif Intell Appl Comput Eng 160:3–24
Kubens BS, Niggemann B, Zänker KS (2001) Prevention of entrance into G2 cell cycle phase by mimosine decreases locomotion of cells from the tumor cell line SW480. Cancer Lett 162:S39–S47
Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P (2010) A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 6(1):343
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–1205
Lewis NE, Schramm G, Bordbar A, Schellenberger J, Andersen MP, Cheng JK, Patel N, Yee A, Lewis RA, Eils R et al (2010) Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat Biotechnol 28(12):1279
Libbrecht MW, Noble WS (2015) Machine learning applications in genetics and genomics. Nat Rev Genet 16(6):321–332
Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG (2011) Role of cholesterol in the development and progression of breast cancer. Am J Pathol 178(1):402–412
Long MR, Ong WK, Reed JL (2015) Computational methods in metabolic engineering for strain design. Curr Opin Biotechnol 34:135–141
López-Agudelo VA, Baena A, Ramirez-Malule H, Ochoa S, Barrera LF, Ríos-Estepa R (2017) Metabolic adaptation of two in silico mutants of mycobacterium tuberculosis during infection. BMC Syst Biol 11(1):107
Machado D, Herrgård M (2014) Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism. PLoS Comput Biol 10(4):e1003580
Mahadevan R, Schilling C (2003) The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 5(4):264–276
Mardinoglu A, Agren R, Kampf C, Asplund A, Uhlen M, Nielsen J (2014) Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat Commun 5:3083
McCullagh P (1984) Generalized linear models. Eur J Oper Res 16(3):285–292
Mienda BS, Salihu R, Adamu A, Idris S (2018) Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets. Futur Microbiol 13(4):455–467
Mitchell TM (1997) Machine learning. 1997, vol 45(37). McGraw Hill, Burr Ridge, pp 870–877
Nozawa T, Suzuki M, Takahashi K, Yabuuchi H, Maeda T, Tsuji A, Tamai I (2004) Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells. J Pharmacol Exp Ther 311(3):1032–1037
Nozawa T, Suzuki M, Yabuuchi H, Irokawa M, Tsuji A, Tamai I (2005) Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells. Pharm Res 22(10):1634–1641
Ohler U, Liao GC, Niemann H, Rubin GM (2002) Computational analysis of core promoters in the Drosophila genome. Genome Biol 3(12):research0087–1
Orth JD, Thiele I, Palsson BØ (2010) What is flux balance analysis? Nat Biotechnol 28(3):245
Pacheco MP, Sauter T (2018) The FASTCORE family: for the fast reconstruction of compact context-specific metabolic networks models. Metabolic network reconstruction and modeling. Springer, Berlin, pp 101–110
Pacheco MP, John E, Kaoma T, Heinäniemi M, Nicot N, Vallar L, Bueb JL, Sinkkonen L, Sauter T (2015) Integrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic network. BMC Genomics 16(1):809
Pacheco MP, Pfau T, Sauter T (2016) Benchmarking procedures for high-throughput context specific reconstruction algorithms. Front Physiol 6(410). https://doi.org/10.3389/fphys.2015.00410
Pacheco MP, Bintener T, Ternes D, Kulms D, Haan S, Letellier E, Sauter T (subm) Identifying and targeting cancer-specific metabolism with network-based drug target prediction
Plaimas K, Mallm JP, Oswald M, Svara F, Sourjik V, Eils R, König R (2008) Machine learning based analyses on metabolic networks supports high-throughput knockout screens. BMC Syst Biol 2(1):67
Plaimas K, Eils R, König R (2010) Identifying essential genes in bacterial metabolic networks with machine learning methods. BMC Syst Biol 4(1):56
Raman K, Pratapa A, Mohite O, Balachandran S (2018) Computational prediction of synthetic lethals in genome-scale metabolic models using fast-SL. Metabolic network reconstruction and modeling. Springer, Berlin, pp 315–336
Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD (2004) Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 6(1):R2
Schomburg I, Chang A, Hofmann O, Ebeling C, Ehrentreich F, Schomburg D (2002) BRENDA: a resource for enzyme data and metabolic information
Schultz A, Qutub AA (2016) Reconstruction of tissue-specific metabolic networks using CORDA. PLoS Comput Biol 12(3):e1004808
zu Schwabedissen HEM, Tirona RG, Yip CS, Ho RH, Kim RB, (2008) Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 68(22):9338–9347
Shaked I, Oberhardt MA, Atias N, Sharan R, Ruppin E (2016) Metabolic network prediction of drug side effects. Cell Syst 2(3):209–213
Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84–87
Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow D et al (2007) Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6(3):820–832
Tarca AL, Carey VJ, Xw Chen, Romero R, Drăghici S (2007) Machine learning and its applications to biology. PLoS Comput Biol 3(6):e116
Thiele I, Swainston N, Fleming RM, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD et al (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol 31(5):419
Vlassis N, Pacheco MP, Sauter T (2014) Fast reconstruction of compact context-specific metabolic network models. PLoS Comput Biol 10(1):e1003424. https://doi.org/10.1371/journal.pcbi.1003424
Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343(6166):80–84
Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM (2015) Identification and characterization of essential genes in the human genome. Science (New York) 350(6264):1096–1101. https://doi.org/10.1126/science.aac7041 (1011.1669)
Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, Network CGAR et al (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45(10):1113–1120
Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR et al (2012) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41(D1):D955–D961
Yizhak K, Gaude E, Le Dévédec S, Waldman YY, Stein GY, van de Water B, Frezza C, Ruppin E (2014) Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. ELIFE 3:e03641
Yizhak K, Le Dévédec SE, Rogkoti VM, Baenke F, de Boer VC, Frezza C, Schulze A, van de Water B, Ruppin E (2014) A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration. Mol Syst Biol 10(8):744
Zampieri G, Coggins M, Valle G, Angione C (2017) A poly-omics machine-learning method to predict metabolite production in CHO cells
Zomorrodi AR, Islam MM, Maranas CD (2014) d-OptCom: dynamic multi-level and multi-objective metabolic modeling of microbial communities. ACS Synth Biol 3(4):247–257
Zou H, Hastie T (2005) Regularization and variable selection via the elastic net. J R Stat Soc: Ser B (Stat Methodol) 67(2):301–320
Zur H, Ruppin E, Shlomi T (2010) iMAT: an integrative metabolic analysis tool. Bioinformatics 26(24):3140–3142
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pacheco, M.P., Bintener, T., Sauter, T. (2019). Towards the Integration of Metabolic Network Modelling and Machine Learning for the Routine Analysis of High-Throughput Patient Data. In: Liò, P., Zuliani, P. (eds) Automated Reasoning for Systems Biology and Medicine. Computational Biology, vol 30. Springer, Cham. https://doi.org/10.1007/978-3-030-17297-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-17297-8_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17296-1
Online ISBN: 978-3-030-17297-8
eBook Packages: Computer ScienceComputer Science (R0)